Duloxetine ameliorates chronic stress-induced depressive behaviors by normalizing hippocampal SIK2-CRTC1 signaling
IntroductionDuloxetine, a serotonin-norepinephrine reuptake inhibitor, is clinically effective for major depressive disorder, yet the intracellular mechanisms underlying its therapeutic actions remain incompletely understood. The hippocampal salt-inducible kinase 2 (SIK2)-CREB-regulated transcriptio...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2026-07-01
|
| Collection: | Frontiers in Pharmacology |
| Sujets: | |
| Accès en ligne: | https://www.frontiersin.org/articles/10.3389/fphar.2026.1836082/full |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
